Arya Sciences Acquisition Corp IV Cl A (NQ: ARYD )

10.45 -0.32 (-2.97%)

Streaming Delayed Price Updated: 12:23 PM EDT, Jul 29, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	917
Open	10.76
Bid (Size)	10.13 (2)
Ask (Size)	10.45 (1)
Prev. Close	10.77
Today's Range	10.28 - 10.76
52wk Range	10.55 - 11.57
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

May 06, 2024

From GENENTA SCIENCE SPA

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Friday

February 25, 2022

During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week...

Via Benzinga

Performance

YTD	-4.39%	-4.39%
1 Month	-9.13%	-9.13%
3 Month	-7.93%	-7.93%
6 Month	-5.17%	-5.17%
1 Year	-1.79%	-1.79%

More News

Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall

February 24, 2022

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

Via Benzinga

The Week In SPAC News - Sunday, Oct. 3

October 03, 2021

Via Talk Markets

Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business

September 29, 2021

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.